OYLER JOHN (CIK 1042047) reported 108 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-25). Recent activity: Sell ONC (1,800 shares), Sell ONC (1,290 shares), Sell ONC (320 shares), Sell ONC (1,650 shares), Sell ONC (1,710 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,800 | $491,949 |
| 2026-06-25 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,290 | $353,613 |
| 2026-06-25 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 320 | $88,030 |
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,650 | $437,042 |
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,710 | $454,835 |
| 2026-06-18 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 333 | $88,809 |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,820 | $1.0M |
| 2026-06-10 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,120 | $303,678 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Buy | 326,976 | $0 |
| 2026-03-10 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Buy | 117,936 | $0 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,896 | $575,626 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 6,389 | $1.9M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,791 | $540,130 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 5,829 | $1.8M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 3,940 | $1.2M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 4,949 | $1.5M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 5,118 | $1.6M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 14,163 | $4.4M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 10,650 | $3.3M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 16,318 | $5.1M |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 2,344 | $729,758 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 121 | $37,744 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 929 | $291,260 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,194 | $376,014 |
| 2025-12-17 | BeOne Medicines Ltd. (ONC) | Chief Executive Officer | Sell | 1,877 | $564,602 |
Source: SEC Form 4 filings · as of 2026-06-25